ORGANIC
LETTERS
2005
Vol. 7, No. 22
4991-4994
A Biocatalytic Route to P-Chirogenic
Compounds by Lipase-Catalyzed
Desymmetrization of a Prochiral
Phosphine−Borane
Daniel Wiktelius,*,† Magnus J. Johansson,*,‡ Kristina Luthman,† and Nina Kann‡
Medicinal Chemistry, Department of Chemistry, Go¨teborg UniVersity,
SE-41296 Go¨teborg, Sweden, and Organic Chemistry, Department of Chemical and
Biological Engineering, Chalmers UniVersity of Technology,
SE-41296 Go¨teborg, Sweden
daniel.wiktelius@chem.gu.se; magjo@chembio.chalmers.se
Received August 17, 2005
ABSTRACT
Available methods for synthesis of P-chirogenic compounds are limited. We set out to find biocatalytical means to introduce asymmetry in
a phosphine borane. After screening different lipases, Candida antarctica lipase B was found to give excellent results in the desymmetrization
of prochiral phosphine boranes. Both enantiomers can be obtained in up to >98% optical purity via acetylation or hydrolysis in processes
−
−
that allow recycling of the substrates.
Asymmetric catalysis is a rapidly growing area of research,
much due to the demands from the pharmaceutical industry
to be able to prepare chiral material in high optical purity
using atom efficient methods. Thus, ligand design and the
development of new asymmetric reactions are becoming
increasingly important. The challenging task of preparing
P-chirogenic phosphines is a bottleneck in the search for new
ligands in transition metal catalysis, since the number of
methods whereby one can synthesize such compounds is still
limited. The preparation and use of P-chirogenic phosphines
has been reviewed.1
most interest; Evans’ method for the desymmetrization of
prochiral phosphine-boranes using (-)-sparteine/s-BuLi3 and
the (-)-ephedrine chiral auxiliary approach by Juge´ et al.4
However, they are both stoichiometric in either chiral base
or auxiliary and have limitations in substrate scope and in
giving high enough optical purity of the desired P-chirogenic
phosphine (the optical purity can, however, often be im-
proved by recrystallization). The preparation of both enan-
tiomers of a P-chirogenic phosphine is rarely reported.2d,5
Herein, we wish to report a biocatalytic approach as a
highly interesting alternative for the preparation of P-
In recent years, focus has been directed toward ligand
design utilizing already established methods to prepare
P-chirogenic compounds.2 Two procedures have gained the
(2) (a) Imamoto, T.; Watanabe, J.; Wada, Y.; Masuda, H.; Yamada, H.;
Tsuruta, H.; Matsukawa, S.; Yamaguchi, K. J. Am. Chem. Soc. 1998, 120,
1635. (b) Yamanoi, Y.; Imamoto, T. J. Org. Chem. 1999, 64, 2988. (c)
Tang, W.; Zhang, X. Angew. Chem., Int. Ed. 2002, 41, 1612. (d) Hoge, G.
J. Am. Chem. Soc. 2003, 125, 10219.
(3) Muci, A. R.; Campos, K. R.; Evans, D. A. J. Am. Chem. Soc. 1995,
117, 9075.
(4) Juge´, S.; Stephan, M.; Laffitte, J. A.; Geneˆt, J. P. Tetrahedron Lett.
1990, 31, 6357.
(5) (a) Johansson, M. J.; Schwartz, L. O.; Amedjkouh, M.; Kann, N. C.
Eur. J. Org. Chem. 2004, 1894. (b) Johansson, M. J.; Schwartz, L. O.;
Amedjkouh, M.; Kann, N. Tetrahedron: Asymmetry 2004, 15, 3531. (c)
Liu, D.; Zhang, X. Eur. J. Org. Chem. 2005, 646.
† Go¨teborg University.
‡ Chalmers University of Technology.
(1) (a) Pietrusiewicz, K. M.; Zabłocka, M. Chem. ReV. 1994, 94, 1375.
(b) Brunel, J. M.; Faure, B.; Maffei, M. Coord. Chem. ReV. 1998, 180,
665. (c) Quin, L. D. A Guide to Organophosphorous Chemistry; John Wiley
& Sons: New York, 2000. (d) Cre´py, K. V. L.; Imamoto, T. Top. Curr.
Chem. 2003, 229, 1. (e) Valentine, D. H.; Hillhouse, J. H. Synthesis 2003,
2437. (f) Tang, W.; Zhang, X. Chem. ReV. 2003, 103, 3029. (g) Johansson,
M. J.; Kann, N. C. Mini-ReV. Org. Chem. 2004, 1, 233.
10.1021/ol0519893 CCC: $30.25
© 2005 American Chemical Society
Published on Web 10/07/2005